ALXO Alx Oncology Holdings Inc

Price (delayed)

$59.29

Market cap

$2.39B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.21

Enterprise value

$1.96B

Highlights
The debt has dropped by 100% year-on-year
The company's gross profit has surged by 88% YoY and by 55% QoQ
The EPS has dropped by 89% since the previous quarter but it is up by 37% year-on-year
The quick ratio has dropped by 57% since the previous quarter but it has increased by 14% year-on-year
ALXO's net income has dropped by 166% year-on-year and by 19% since the previous quarter
Alx Oncology Holdings's equity has decreased by 2.6% QoQ

Key stats

What are the main financial stats of ALXO
Market
Shares outstanding
40.23M
Market cap
$2.39B
Enterprise value
$1.96B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.69
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$53.64M
EBITDA
-$53.54M
Free cash flow
-$34.49M
Per share
EPS
-$5.21
Free cash flow per share
-$0.86
Book value per share
$10.43
Revenue per share
$0
TBVPS
$10.81
Balance sheet
Total assets
$432.91M
Total liabilities
$14.43M
Debt
$0
Equity
$418.48M
Working capital
$418.2M
Liquidity
Debt to equity
0
Current ratio
30.6
Quick ratio
30.42
Net debt/EBITDA
8.03
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-18.7%
Return on equity
-22.7%
Return on invested capital
N/A
Return on capital employed
-12.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALXO stock price

How has the Alx Oncology Holdings stock price performed over time
Intraday
-1.69%
1 week
-0.62%
1 month
6.27%
1 year
N/A
YTD
-31.22%
QTD
-19.6%

Financial performance

How have Alx Oncology Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
-$479,000
Operating income
-$53.16M
Net income
-$54.47M
Gross margin
N/A
Net margin
N/A
ALXO's net income has dropped by 166% year-on-year and by 19% since the previous quarter
ALXO's operating income has shrunk by 116% YoY and by 19% QoQ
The company's gross profit has surged by 88% YoY and by 55% QoQ

Growth

What is Alx Oncology Holdings's growth rate over time

Valuation

What is Alx Oncology Holdings stock price valuation
P/E
N/A
P/B
5.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 89% since the previous quarter but it is up by 37% year-on-year
Alx Oncology Holdings's equity has decreased by 2.6% QoQ

Efficiency

How efficient is Alx Oncology Holdings business performance
ALXO's return on equity is up by 42% since the previous quarter
The return on assets is up by 21% year-on-year and by 17% since the previous quarter

Dividends

What is ALXO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALXO.

Financial health

How did Alx Oncology Holdings financials performed over time
The total liabilities has surged by 132% since the previous quarter and by 55% year-on-year
The quick ratio has dropped by 57% since the previous quarter but it has increased by 14% year-on-year
The debt is 100% smaller than the equity
The debt has dropped by 100% year-on-year
Alx Oncology Holdings's debt to equity has soared by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.